Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01252953
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Active, not recruiting REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification
Condition: Atherosclerotic Cardiovascular Disease
Interventions: Drug: anacetrapib;   Drug: placebo anacetrapib

Indicates status has not been verified in more than two years